[ad_1]
The coronavirus vaccine, developed by the University of Oxford and AstraZeneca, “works perfectly” and generates strong immunity. This was found in a study cited by The Sun and Dariknews.bg.
A participant in the COVID vaccine tests died
The team from the prestigious university is considered the most advanced in the development of a safe vaccine against the virus. Their tests are currently in “phase 3” when they inject it into thousands of volunteers. Upon successful completion of the stage, your approval for mass deployment follows.
So far, the vaccine has successfully passed the previous phases: preclinical (tested in experimental animals), first phase (injection of a small group of people) and second phase (application to hundreds of volunteers).
Britain’s Deputy Medical Inspector Professor Jonathan Van-Tam told parliament that the UK Health Service planned to launch the vaccine shortly after Christmas.
Oxford coronavirus vaccine is being tested in humans in India
Previous tests showed that the vaccine successfully and safely triggered an immune response in volunteers. Vaccines typically use a weakened virus or small amounts, but the innovative approach developed at Oxford causes the body to create a certain amount of infection on its own. Researchers at the University of Bristol believe that this new technique works successfully against the coronavirus.
Dr David Matthews of the University of Bristol School of Cellular and Molecular Medicine, who led the team, said: “Until now, technology could not provide answers so clearly, but now we know that the vaccine does everything that We were hoping. This is good news in the fight against the disease. “
Last month, AstraZeneca halted a pilot study of the vaccine after a British volunteer entered the hospital with a suspected neurological complication. Once the problem was cleared up, testing was resumed in the UK.
A dose of vaccine against COVID-19 in EU countries will cost 1.78 euros
EU countries are expected to receive the vaccine between December 2020 and June 2021, with a percentage distribution of the population. We remind you that the European Commission has signed a contract for the supply of 300 million doses.
There are currently 48 different coronavirus vaccines in the world in clinical trials, 11 of which are in the final stages. The pandemic has forced scientists to shorten the time to develop a new vaccine, which typically lasts between 8 and 10 years.
The first coronavirus vaccines are likely to protect against severe forms of the disease and prevent a COVID-19 outbreak, but not the infection itself. It remains to be seen how long the protective effect of the vaccine will last.
Testing a COVID-19 Vaccine in Children
READ ALL ABOUT CORONAVIRUS IN OUR COUNTRY AND THROUGHOUT THE WORLD HERE
Subscribe FREE to the nova.bg newsletter HEREto receive the most important news of the day in your email.
[ad_2]
